GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Cash-to-Debt

Resonate Blends (Resonate Blends) Cash-to-Debt : 0.01 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Resonate Blends's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.01.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Resonate Blends couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Resonate Blends's Cash-to-Debt or its related term are showing as below:

KOAN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0   Med: 0.08   Max: 2.16
Current: 0.01

During the past 13 years, Resonate Blends's highest Cash to Debt Ratio was 2.16. The lowest was 0.00. And the median was 0.08.

KOAN's Cash-to-Debt is ranked worse than
97.61% of 1046 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs KOAN: 0.01

Resonate Blends Cash-to-Debt Historical Data

The historical data trend for Resonate Blends's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Resonate Blends Cash-to-Debt Chart

Resonate Blends Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.17 0.01 0.07 -

Resonate Blends Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.01

Competitive Comparison of Resonate Blends's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resonate Blends's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Resonate Blends's Cash-to-Debt falls into.



Resonate Blends Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Resonate Blends's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Resonate Blends's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resonate Blends  (OTCPK:KOAN) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Resonate Blends Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Resonate Blends's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Resonate Blends (Resonate Blends) Business Description

Traded in Other Exchanges
N/A
Address
26565 Agoura Road, Suite 200, Calabasas, CA, USA, 91302
Resonate Blends Inc is a cannabis/hemp-based holding company. It is focused on a vertically integrated and valued-added Wellness and Lifestyle brand.
Executives
Richard Hoge 10 percent owner C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin officer: Chief Operating Officer 26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer director, officer: Chief Executive Officer 26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen 10 percent owner, officer: COO 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello 10 percent owner, officer: VP of Sales 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi director, 10 percent owner, officer: CEO 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii director
Gregory Oliver Sargent 10 percent owner 1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester officer: Vice President 3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane other: Controller 50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley director 945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley director 2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr director 2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee officer: VP of Product Development
Jeffrey Longoria officer: VP of Sales